An international life sciences recruitment firm has completed a management buyout (MBO) with founder Andrew Buxton.
The Leeds-headquartered company will see the management team of Tom Maskill, CEO, Sheridan White, CRO, and Ben Paice, COO, take majority ownership.
The deal, for an undisclosed sum, will provide a platform for global growth. The firm plans to grow by recruiting people from diverse backgrounds and is developing a wide range of career paths, from apprenticeships to retraining.
Commenting on the deal, Tom Maskill, CEO of Hartmann Young, said: “We are moving to scale all elements of the business with ambitious, yet sustainable, growth in mind. One of our key goals is to create opportunities for people in the region. For now, we are focusing on providing career opportunities in Leeds through various pathways, and we will be sharing exciting plans on this in due course. Expansion beyond Leeds forms part of the long-term plan, so very exciting times lie ahead for our team.
“There is enormous potential to become a recognised leader in the life sciences sectors, and we’re investing and ramping up the processes we need to deliver excellent service to our clients and an exceptional experience for our highly talented team. We aim to move recruitment away from its transactional reputation to a value-added, longer-term relationship approach, focussing on longevity with our global partners.”
Andrew Buxton, founder of Hartmann Young, said: “I’ve known Tom for years and bringing him into the business has helped to accelerate its growth. The MBO allows him, with the support of a super talented management team, to take the business to the next level.”
